The BAPW (British Association of Pharmaceutical Wholesalers) has appealed for pharmacies and manufacturers to support third-party monitoring and reporting of branded drug supplies. Critical deliberation should be given to the establishment of a robust, objective monitoring and survey service of medicines to pharmacies and dispensing doctors, and this would need to have the support of
Cuts in patient services are difficult to rationalise when there are many ways hospitals could improve their efficiency, a major new evaluation prepared for the Nuffield Trust by Jeremy Hurst and Sally Williams has concluded. While inefficiencies in areas such as rates of day case surgery, length of stay and the purchasing of hospital supplies
The international landscape for investigative sites, research centres that conduct clinical research, has continued to decline over the past five years, according to US-based information services provider CenterWatch. The global economic downturn is combining with decreasing study numbers, budget pressures, protocol complexity and regulatory burdens to turn experienced investigators off clinical research and destabilise the
Roughly 80% of doctors are concerned about how they will be treated when they grow old and fear that present guidelines to deal with the ageing population are not “comprehensive, realistic or sufficiently funded to address future demand”. That is one of the main findings of a recent study from the Economist Intelligence Unit (EIU),
UK Health Secretary, Andrew Lansley, has announced that one-year pilot schemes for a new initiative which allow patients to choose their GP practice will start in April this year. The trials, which will run in parts of central London, Manchester/Salford and Nottingham, will allow the public, for the first time, to select whether they want
The EU’s (European Union) proposal for a new directive on public procurement will permit “more scope for negotiating with suppliers,” according to the NHS Confederation. The plans, which have been published by the European Commission this week, contain a number of provisions intended to simplify the rules for the purchasing goods and services, and making
The multiple myeloma drug therapy market will experience robust growth averaging 5.6% annually from 2010 to 2020 in seven of the world’s major markets, according to new projections. Growth in these markets – US, Italy, Spain, UK, France, Germany and Japan – will be driven by additional penetration of Celgene’s Revlimid (lenalidomide) into the first-line
We would like to wish all of Only Medics’ clients and candidates a very Merry Christmas and Best Wishes for the New Year. Thank you for your business in 2011 and we look forward to working with you in 2012! Please note the following office hours: Only Medics will be closed from midday on Friday,
The NHS is to gain a funding boost of over £2.5 billion to deliver services to patients in 2012-13, Health Secretary Andrew Lansley has announced. £91.6 billion will be given to Primary Care Trusts, representing a 2.8% rise in total allocations. The funding breaks down as follows: £87.5 billion for Primary Care Trusts to provide care
Galapagos of Belgium yesterday announced that they have reached milestones in its osteoarthritis alliance with Servier, resulting in a payment of 4 million euros from the French drugmaker. In July 2010, teamed up for a collaboration that could be worth around 300 million euros to the Mechelen-based group, which is responsible for the discovery and
